Individualization of treatment strategies. - Wikidata - awgldk - TriplyDB

Individualization of treatment strategies.

Individualization of treatment strategies.

http://www.wikidata.org/entity/Q37933161

about

Personalized medicine and cancer.Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review.Exercise for improving bone health in women treated for stages I-III breast cancer: a systematic review and meta-analyses.

P2860

Q34608577-610E0B0F-0E53-49D4-88D4-E71A895FC86D Q38239596-F3007E7B-804C-4C26-A8E9-E849D47BD0FE Q38714539-45128DDE-5032-4724-8E1F-0A8CDC86CDE4

P2860

Individualization of treatment strategies.

http://www.wikidata.org/entity/Q37933161

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Individualization of treatment strategies.

@en

Individualization of treatment strategies.

@nl

type

label

Individualization of treatment strategies.

@en

Individualization of treatment strategies.

@nl

prefLabel

Individualization of treatment strategies.

@en

Individualization of treatment strategies.

@nl

P1433

Q37933161-8AC19035-04D7-4222-9961-73D9A483B09B

P1476

Q37933161-A1626447-204D-4B21-B160-8D1C0F0D6A3C

P2093

Q37933161-2C4441A3-341F-44E9-B695-2B60828B02C5

Q37933161-353B3681-DAD5-4D54-9611-B89F26E8886D

Q37933161-793DC42C-346D-45CD-810D-6BF742E81580

Q37933161-8D395F4B-2D2F-4EDC-B604-9996D763D016

Q37933161-9BAF630E-654E-4BD6-B93D-00D276C122CF

Q37933161-B91870FC-4A4C-447D-A341-CC96623B6EC1

Q37933161-D382281F-7132-4BB6-B737-640AC30433D3

Q37933161-F015A75A-0B12-4622-AA86-20929F4E8C4D

Q37933161-FCAE530D-5F35-442F-8649-3447AC78D05D

P2860

Q37933161-097F8E94-E802-4F4E-81D4-7AFF03BE1225

Q37933161-0FBE29FE-FE0C-4938-97B2-F5125E64CE84

Q37933161-174CA3CD-FAAF-4C75-898D-82C62CF9FD20

Q37933161-17876C45-5B4D-40E4-AD53-9F9577C67B27

Q37933161-21AEED08-A7C7-4BAF-9281-C53FD8E06553

Q37933161-2C548968-D807-4AA7-9323-17FC8E2C0586

Q37933161-2C77B185-F824-4832-9034-9C09E020F07A

Q37933161-357053CE-46FA-4898-8725-BED46E1A8C9C

Q37933161-3B900A98-9977-4F17-B27B-5228520CBF05

Q37933161-3BF0573B-9655-4141-89AA-780A1665D046

P2888

Q37933161-623371F2-D908-4CCB-9B53-1B792D10FEC4

P304

Q37933161-F9801FEF-8F86-4A60-AB0C-D58E799386C4

P31

Q37933161-9F843593-33C7-4D1F-932D-AE8994676F7F

P356

Q37933161-D9BDBD1A-68B2-4B23-A443-E62B73138E00

P407

Q37933161-B519F17E-2120-4711-8181-16180F0B5585

P478

Q37933161-FBE5E995-EB5E-4639-869D-8BF52F4E656B

P577

Q37933161-95448178-4D73-4010-B996-D5F8CBD1AB41

P698

Q37933161-02780CA0-A80D-4164-BAC2-2743B66E9AE8

P356

S12325-011-0033-1

P1433

Advances in Therapy

P1476

Individualization of treatment strategies.

@en

P2093

A Fernández Ortega

http://www.w3.org/2001/XMLSchema#string

A García Arias

http://www.w3.org/2001/XMLSchema#string

C Saura Manich

http://www.w3.org/2001/XMLSchema#string

G Viñas Villaró

http://www.w3.org/2001/XMLSchema#string

J Cortés Castán

http://www.w3.org/2001/XMLSchema#string

L Jolis López

http://www.w3.org/2001/XMLSchema#string

R Villanueva Vázquez

http://www.w3.org/2001/XMLSchema#string

S González Jiménez

http://www.w3.org/2001/XMLSchema#string

X González Farré

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

[Validation and clinical application of MammaPrint® in patients with breast cancer].

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

Coprescription of tamoxifen and medications that inhibit CYP2D6.

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

P2888

s12325-011-0033-1

P304

19-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-011-0033-1

http://www.w3.org/2001/XMLSchema#string

P407

P478

28 Suppl 6

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21922393

http://www.w3.org/2001/XMLSchema#string